Evidence map›Paper›PMID 23900392›Full record

ArticleOncotarget2013

Radiation therapy induces the DNA damage response in peripheral blood.

Christopher J Bakkenist, R Kenneth Czambel, David A Clump, Joel S Greenberger, Jan H Beumer, John C Schmitz

Open access · hybridAbstract read
In one paragraph

Article in Oncotarget, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Systemic effects ofEuropean journal of nuclear medicine and molecular imaging · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Phase I study of veliparib in combination with gemcitabine.Cancer chemotherapy and pharmacology · 2017
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Christopher J BakkenistDepartment of Radiation Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
R Kenneth Czambel
David A Clump
Joel S Greenberger
Jan H Beumer
John C Schmitz
University of Pittsburgh · USUPMC Hillman Cancer Center · US

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Leonard J. Appleman · 1988 to 2026
$158.0M
Vitamin D3 Modulation of Inflammation and Lung Cancer RiskP50CA090440 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI WEISSFELD, JOEL L · 2001 to 2015
$34.6M
NCI ET-CTN with Phase i Emphasis at UPCIUM1CA186690 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JOHN C. BYRD, Farshid Dayyani · 2014 to 2026
$9.1M
Phase I Clinical Trials of Novel Anticancer AgentsU01CA099168 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHU, EDWARD · 2003 to 2013
$5.0M
Regulation of DNA replication fork progression by ATM kinase activityR01CA148644 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BAKKENIST, CHRISTOPHER J. · 2011 to 2015
$1.3M
NCI NIH HHS CA148644NCI NIH HHS P30 CA047904NCI NIH HHS P30CA047904NCI NIH HHS P50 CA090440NCI NIH HHS P50CA090440NCI NIH HHS R01 CA148644NCI NIH HHS U01 CA099168NCI NIH HHS U01CA099168NCI NIH HHS UM1 CA186690
6 · The paper itself

Abstract

Stereotactic body radiation therapy (SBRT) is a radiotherapy modality that delivers highly conformal, ablative doses to a well-defined target. Here, using a semiquantitative multiplexed assay to analyze ATM and H2AX phosphorylation, we show that ATM kinase activity in peripheral blood mononuclear cells is induced following SBRT. This observation of a systemic ATM kinase-dependent DNA damage response in the peripheral blood is unprecedented and promotes the use of ATM serine-1981 phosphorylation as a predictive biomarker for DNA damaging modalities and ATM inhibitors.

Indexed as

DNA DamageAtaxia Telangiectasia Mutated ProteinsBiomarkers, TumorCell Line, TumorDNA, NeoplasmHistonesHT29 CellsHumansLeukocytes, MononuclearNeoplasmsPhosphorylationRadiosurgeryAtaxia Telangiectasia Mutated ProteinsATM protein, humanBiomarkers, TumorDNA, NeoplasmH2AX protein, humanHistones

Identifiers

PMID23900392
PMCPMC3787146
OpenAlexW1492448373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.